Tsochatzis, Emmanuel A. http://orcid.org/0000-0001-5069-2461
Article History
First Online: 8 December 2021
Competing interests
: E.A.T. serves on advisory boards for Engitix, Intercept, Gilead, NovoNordisk, Orphalan and Pfizer, and has received speaker fees from Intercept, Gilead, Oprhalan.